Publications by authors named "Jonathan Oliva"

Claim this Profile
D
Discovery of an Orally Efficacious Pyrazolo[3,4-]pyrimidine Benzoxaborole as a Potent Inhibitor of .
Makafui Gasonoo, Soumitra Guin, José E Teixeira, Edmund Oboh, Anusha Gokanapalle, Jonathan Oliva

J Med Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIX transcription factors are necessary for the activation of DUX4 expression in facioscapulohumeral muscular dystrophy.
Amelia Fox, Jonathan Oliva, Rajanikanth Vangipurapu, Francis M Sverdrup

Skelet Muscle· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal variation in p38-mediated regulation of DUX4 in facioscapulohumeral muscular dystrophy.
Rajanikanth Vangipurapu, Jonathan Oliva, Amelia Fox, Francis M Sverdrup

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines against Reveals Remarkable Role of Fluorine.
Tanner J Schubert, Edmund Oboh, Hannah Peek, Emily Philo, José E Teixeira, Jonathan Oliva

J Med Chem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy.
Jonathan Oliva, Scott Galasinski, Amelia Richey, Amy E Campbell, Marvin J Meyers

J Pharmacol Exp Ther· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesicles.
Jonathan Bruno, Nicola Pozzi, Jonathan Oliva, John C Edwards

J Biol Chem· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells.
Amy E Campbell, Jonathan Oliva, Matthew P Yates, Jun Wen Zhong, Sean C Shadle

Skelet Muscle· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in Mice.
Barbara Ulmasov, Brent A Neuschwander-Tetri, Jinping Lai, Vladimir Monastyrskiy, Trisha Bhat, Jonathan Oliva

Cell Mol Gastroenterol Hepatol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory Diarrhea.
David W Griggs, Michael J Prinsen, Jonathan Oliva, Mary A Campbell, Stacy D Arnett

J Pharmacol Exp Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents.
Marvin J Meyers, Elizabeth J Anderson, Sarah A McNitt, Thomas M Krenning, Megh Singh, Jonathan Oliva

Bioorg Med Chem· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasonic thermal damage during robotic hysterectomy.
Jason Massengill, Eric Lombardini, Jonathan Oliva, Jerome Buller, Daniel Gruber

J Robot Surg· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of aminohydantoins as a novel class of antimalarial agents.
Marvin J Meyers, Micky D Tortorella, Jing Xu, Limei Qin, Zhengxiang He, Jonathan Oliva

ACS Med Chem Lett· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis